Primary prevention: HBV vaccination in hemodialysis unit.
The authors evaluated the response rate to HBV vaccination in 27 dialyzed patients. In the 1st stage, the response was 70.37%; nonresponder patients (n = 8) were treated with thymostimulin and revaccinated. The total percentage increased to 85.18%. In order to restore a normal response, the authors suggest to treat nonresponder patients with thymostimulin before revaccination.
Sapio
C
C
Servizio Emodialisi di Castrovillari, Italy.
Bonifati
A
A
Confessore
A
A
Gatti
M
M
Maimone
I
I
Minella
M P
MP
Scarpino
L
L
D'Alessandro
C
C
D000328:Adult; D005260:Female; D006509:Hepatitis B / Q000517:prevention & control; D006510:Hepatitis B Antibodies / Q000097:blood; D017325:Hepatitis B Vaccines; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*; D013949:Thymus Extracts / Q000008:administration & dosage; D014614:Vaccines, Synthetic / Q000008:administration & dosage; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage / Q000627:therapeutic use*
D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines; D013949:Thymus Extracts; D014614:Vaccines, Synthetic; D014761:Viral Hepatitis Vaccines; C031407:thymostimulin